Based on the above analysis that showed similar results, it can be concluded that treatment with oHSV-4-1BBL can dramatically reverse the exhaustion of CD8+ T cells in pancreatic tumors by reducing terminal exhaustion cells and increasing transitional exhaustion T cells. The gene discussed is CD8A; the disease is pancreatic neoplasm.